Senior insider sale
Chief Operating Officer at ESPERION THERAPEUTICS, INC. — senior position signals high conviction
$256.4K
76.67K shares
What this filing means
KOENIG SHELDON L. plans to sell 76.67K shares of ESPERION THERAPEUTICS, INC. valued at approximately $256.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/17/2025ACC: 0001959173-25-007814
Officer· Chief Operating Officer
Since Dec 2020
76.67K
Shares to sell
$256.4K
Approx. market value
48.24K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
12/15/2025
48.24KTotal acquired48.24K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/15/2025 | Restricted Stock Vesting Compensation | 48.24K | — |
| Total | 48.24K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
28.43K
Market value
$79.2K
9/17/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
48.24K
Market value
$177.2K
12/17/2025
Total
Units
76.67K
Value
$256.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/17/2025 | 28.43K | $79.2K | — | Completed |
| Planned — Approximate Date | ||||
12/17/2025 | 48.24K | $177.2K | NASDAQ | Planned |
| Total | 76.67K | $256.4K | ||